© 2022 Osprey Medical Inc. All rights reserved.
Osprey Medical, DyeVert, DyeMINISH, and Be Kind to Kidneys are registered trademarks of Osprey Medical, Inc. in the United States and other countries.
Financial Information
Osprey Medical (OSP) IPO
Osprey Medical completed its initial public offering of CDIs (CHESS Depositary Interests) and began trading on the Australian Securities Exchange (“ASX”) on May 2, 2012 under the symbol “OSP”.
- Ownership interests in Osprey Medical may be held in either CDIs or shares of common stock.
- Only CDIs may be traded on the ASX.
- Two CDIs are equal to one share of common stock.
Notice of Exercise of Options Form
| Title | Size | View |
|---|---|---|
| Notice of Exercise of Options Form | 158 KB | Download |
Corporate Fact Sheet
| Title | Size | View |
|---|---|---|
| Osprey Medical Fact Sheet September 2020 | 2 MB | Download |
Investor Newsletter
| Title | Size | View |
|---|---|---|
| Osprey Medical Investor Newsletter June 2019 | 3 MB | Download |
Annual Report
| Title | Size | View |
|---|---|---|
| Osprey Medical 2021 Annual Report | 2 MB | Download |
Analyst Reports
| Title | Size | View |
|---|---|---|
| Osprey Medical: Poised for Flight | 803 KB | Download |